Background:

Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine| which| in vitro| suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.|online information:CXCL2 entry|pharmaceutical:GRO-beta(5-73) is available under the name Garnocestim as immunomodulator. It is used prior to hematopoietic transplantation for peripheral blood stem cell mobilization and reduction of incidence| duration| and/or severity of chemotherapy induced cytopenias.|PTM:The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells.|Belongs to the intercrine alpha (chemokine CxC) family.|

Classification:

Primary antibody

Alternative names:

GROβ; C-X-C motif chemokine 2; Growth-regulated protein beta; Gro-beta; Macrophage inflammatory protein 2-alpha; MIP2-alpha; GRO-beta;5-73; GRO-beta-T; Hematopoietic synergistic factor; HSF; SB-251353;

Species reactivity:

Human, Rat, Mouse

Host:

Rabbit

Isotype:

IgG

Immunogen:

Synthesized peptide derived from human GROβ

Concentration:

1 mg/ml

Molecular weight:

11770

Applications:

WB, ELISA

Storage:

-20°C for 1 year

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com